Temporary deterioration of health and behavior during pexidartinib-mediated microglia depletion and repopulation in progranulin-deficient mice
Preprint
Abstract
Progranulin (PGRN) is a neurotrophic and anti-inflammatory factor produced mainly by neurons and microglia in the central nervous system. Progranulin haploinsufficiency causes frontotemporal dementia (FTD). In a previous study we showed that transgenic restoration of progranulin in neurons in progranulin knockout mice (NestinGrn KOBG k nock o ut b ack g round) did not prevent the dementia-like phenotype. Here, we assessed if pharmacologic microglia depletion via PLX3397-diet (CSF1R-antagonist) had therapeutic value in these mice. Microglia depletion and spontaneous repopulation was confirmed in immunofluorescence and rtPCR studies. There was no difference in depletion or repopulation efficiency between NesGrn KOBG, PGRN KO and heterozygous (het) PGRN mice, but microglia repopulated faster than in control Grn-flfl mice, and the morphology of primary PGRN deficient microglia during repopulation was closer to homeostatic microglia, and it was accompanied by a remarkable restoration of dendritic spines and synaptic structures. Regardless of these positive effects, NesGrn KOBG and PGRN het mice experienced serious side effects during microglia depletion which peaked around the microglia nadir. Overactivity and excessive grooming escalated and caused serious skin lesions. Bulk transcriptomic and metabolomic studies in the brain taken 8 weeks after the end of PLX-diet clearly revealed differences between genotypes but mostly no lasting impact of PLX-diet, except for a further increase of proinflammatory genes, cathepsins and complement factors in PLX-treated groups. Cell type specific lipidomic studies revealed a time dependent switch not only in microglia but also astrocytes upon PLX3397 treatment. While nadir-microglia were triglyceride-laden, repopulated microglia returned to normal TG levels but were enriched in ether-bound phosphatidylcholines (PC-O) and lysophosphatidylglycerol species which are pro-inflammatory lipids; and astrocytes overtook the TG burden during repopulation. Our data suggest that microglia depletion may cause a deterioration in progranulin-deficiency.Keywords
This publication has 90 references indexed in Scilit:
- TSC-associated microglial hyperactivity: enhanced calcium signaling, metabolism, and phagocytosisActa Neuropathologica, 2026
- Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrityAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2025
- Phase 1 study of latozinemab in progranulin‐associated frontotemporal dementiaAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2024
- Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelinationActa Neuropathologica, 2023
- Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin MutationsNeurotherapeutics, 2023
- Adeno‐associated virus serotype 1‐based gene therapy for FTD caused by GRN mutationsAnnals of Clinical and Translational Neurology, 2020
- Prevention of age-associated neuronal hyperexcitability with improved learning and attention upon knockout or antagonism of LPAR2Cellular and Molecular Life Sciences, 2020
- Loss of synaptic zinc transport in progranulin deficient mice may contribute to progranulin-associated psychopathology and chronic painBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Hypothalamic lipid‐laden astrocytes induce microglia migration and activationFEBS Letters, 2017
- Progranulin expression in the developing and adult murine brainJournal of Comparative Neurology, 2010